Structures by: Görbitz C. H.
Total: 230
6,7-Dimethoxy-1-(4-nitrophenyl)quinolin-4(1<i>H</i>)-one
C17H14N2O5
Acta Crystallographica Section E (2017) 73, 3 441-444
a=8.3736(4)Å b=11.7694(5)Å c=15.5623(8)Å
α=90° β=93.2510(10)° γ=90°
<i>L</i>-Leucyl-<i>L</i>-isoleucine 2,2,2-trifluoroethanol monosolvate
C12H24N2O3,C2H3F3O
Acta Crystallographica Section E (2016) 72, 5 635-638
a=10.947(3)Å b=12.999(4)Å c=12.440(4)Å
α=90° β=101.833(4)° γ=90°
<i>DL</i>-methionine
C5H11NO2S
Acta Crystallographica Section E (2014) 70, 11 341-343
a=9.877(2)Å b=4.6915(10)Å c=32.603(6)Å
α=90° β=106.250(10)° γ=90°
<i>DL</i>-methionine
C5H11NO2S
Acta Crystallographica Section E (2014) 70, 11 337-340
a=16.811(5)Å b=4.7281(14)Å c=9.886(3)Å
α=90° β=101.950(7)° γ=90°
Seleno-<i>L</i>-cystine dihydrochloride
C6H14N2O4Se22,2(Cl)
Acta Crystallographica Section E (2015) 71, 6 726-729
a=18.8045(16)Å b=5.2529(4)Å c=7.2719(6)Å
α=90° β=102.2190(10)° γ=90°
(2S)-2-amino-3-(1H-indol-3-yl)propanoic acid
C11H12N2O2
Acta crystallographica. Section B, Structural science (2012) 68, Pt 5 549-557
a=11.430(3)Å b=11.464(4)Å c=35.606(9)Å
α=84.421(4)° β=87.694(4)° γ=60.102(2)°
Dibromido{<i>N</i>-[(pyridin-2-yl-κ<i>N</i>)methylidene]picolinohydrazide-κ^2^<i>N</i>,<i>O</i>}cadmium methanol monosolvate
C12H10Br2CdN4O,CH4O
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 5 698-701
a=7.5482(4)Å b=15.7571(8)Å c=14.6407(6)Å
α=90° β=95.132(4)° γ=90°
Diiodido{<i>N</i>-[(pyridin-2-yl-κ<i>N</i>)methylidene]picolinohydrazide-κ^2^<i>N</i>,<i>O</i>}cadmium
C12H10CdI2N4O
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 5 698-701
a=7.5264(7)Å b=13.1325(12)Å c=16.5718(15)Å
α=90° β=94.3840(10)° γ=90°
Α-thymidine
C10H14N2O5
Acta Crystallographica Section E (2005) 61, 5 o1207-o1209
a=5.838(2)Å b=9.883(4)Å c=10.576(4)Å
α=107.225(14)° β=100.203(14)° γ=98.894(14)°
Cyclo(L-isoleucyl-L-isoleucyl)
C12H22N2O2
Acta Crystallographica Section E (2006) 62, 6 o2358-o2360
a=6.242(9)Å b=10.814(15)Å c=19.79(3)Å
α=90.00° β=90.00° γ=90.00°
L-Alanyl-L-threonine
C7H14N2O4
Acta Crystallographica Section E (2004) 60, 6 o951-o953
a=6.03990(10)Å b=9.7642(2)Å c=14.6820(4)Å
α=90.00° β=90.00° γ=90.00°
L-threonyl-L-alanine
C7H14N2O4
Acta Crystallographica Section E (2005) 61, 7 o2012-o2014
a=13.9136(7)Å b=13.9136(7)Å c=4.7065(4)Å
α=90.00° β=90.00° γ=90.00°
L-Phenylalanine nitrate (4/1)
C9H12N1O21,N1O31,3C9H11N1O2
Acta Crystallographica Section E (2001) 57, 2 o192-o194
a=30.285(8)Å b=5.3022(13)Å c=22.317(6)Å
α=90.00° β=102.263(4)° γ=90.00°
L-alanyl-L-2-aminobutyric acid
C7H14N2O3
Acta Crystallographica Section E (2005) 61, 11 o3735-o3737
a=15.665(5)Å b=5.470(2)Å c=17.147(7)Å
α=90.00° β=108.233(9)° γ=90.00°
N-formylglycine
C3H5NO3
Acta Crystallographica Section E (2004) 60, 5 o841-o843
a=7.4378(15)Å b=9.1650(19)Å c=7.1002(14)Å
α=90.00° β=116.348(3)° γ=90.00°
N-acetyl-L-alanine
C5H9NO3
Acta Crystallographica Section E (2004) 60, 5 o860-o862
a=10.3879(2)Å b=11.5449(3)Å c=5.74260(10)Å
α=90.00° β=90.00° γ=90.00°
L-Leucyl-L-isoleucine 0.75-hydrate
C12H24N2O3,0.75H2O
Acta Crystallographica Section E (2004) 60, 4 o647-o650
a=29.633(7)Å b=29.633(7)Å c=12.035(3)Å
α=90.00° β=90.00° γ=120.00°
Ammonium L-alanyl-L-phenylalaninate
N1H4,C12H15N2O3
Acta Crystallographica Section E (2004) 60, 11 o2065-o2067
a=8.0494(12)Å b=6.4253(9)Å c=12.950(2)Å
α=90.00° β=92.248(4)° γ=90.00°
Cytosine N-benzoylglycine monohydrate
C9H8NO3,C4H6N3O,H2O
Acta Crystallographica Section E (2004) 60, 11 o1945-o1947
a=11.4821(2)Å b=7.21070(10)Å c=18.2817(3)Å
α=90.00° β=106.6920(10)° γ=90.00°
C12H24N2O3,0.91H2O
C12H24N2O3,0.91H2O
Acta Crystallographica Section E (2004) 60, 4 o626-o628
a=34.243(2)Å b=5.3251(4)Å c=18.1469(12)Å
α=90.00° β=114.830(2)° γ=90.00°
L-Asparaginyl-L-valine
C9H17N3O4,1.33H2O1
Acta Crystallographica Section E (2005) 61, 3 o524-o527
a=9.0002(5)Å b=15.0542(7)Å c=27.4541(14)Å
α=90.00° β=90.00° γ=90.00°
Disodium cytidine-5'-monophosphate 6.07-hydrate methanol 0.27-solvate
2Na,C9H12N3O8P2,6.07H2O,0.27CH4O
Acta Crystallographica Section E (2005) 61, 3 m554-m556
a=8.97500(10)Å b=20.4196(3)Å c=21.9152(4)Å
α=90.00° β=90.00° γ=90.00°
L-Leucyl-L-leucine 2-methyl-1-propanol (1:1)
C16H34N2O4
Acta Crystallographica Section C (1999) 55, 4 670-672
a=10.31790(10)Å b=13.63970(10)Å c=27.1830(5)Å
α=90.00° β=90.00° γ=90.00°
DL-Valine
C5H11NO2
Acta Crystallographica Section C (1996) 52, 7 1759-1761
a=5.2220(10)Å b=5.4060(10)Å c=10.838(2)Å
α=90.890(10)° β=92.340(10)° γ=110.020(10)°
L-cysteine
C3H7NO2S
Acta Crystallographica Section C (1996) 52, 7 1756-1759
a=9.441(2)Å b=5.2220(10)Å c=11.337(4)Å
α=90.00° β=109.00(2)° γ=90.00°
C8H16N2O3
C8H16N2O3
Acta Crystallographica Section C (1996) 52, 7 1764-1767
a=14.424(4)Å b=14.424(4)Å c=9.996(6)Å
α=90° β=90° γ=120°
L-leucine
C6H13NO2
Acta Crystallographica Section C (1996) 52, 7 1754-1756
a=9.562(2)Å b=5.301(1)Å c=14.519(3)Å
α=90.° β=94.20(2)° γ=90.°
DL-Norleucine
C6H13NO2
Acta Crystallographica Section C (1996) 52, 7 1761-1764
a=31.067(5)Å b=4.7170(10)Å c=9.851(2)Å
α=90.00° β=91.37(2)° γ=90.00°
Gly-Leu-Tyr
C20H37N3O8
Acta Crystallographica Section C (1996) 52, 8 2087-2090
a=9.179(2)Å b=11.104(3)Å c=12.202(2)Å
α=84.08(2)° β=83.98(1)° γ=75.52(2)°
L-Isoleucine:D-Alanine
C6H13N1O2,C3H7N1O2
Acta Crystallographica Section B (1999) 55, 3 424-431
a=9.8944(2)Å b=4.74250(10)Å c=12.9045(2)Å
α=90.00° β=93.3740(10)° γ=90.00°
L-Isoleucine:D-aminobutyric acid
C6H13N1O2,C4H9N1O2
Acta Crystallographica Section B (1999) 55, 3 424-431
a=26.9873(6)Å b=4.74710(10)Å c=9.9652(2)Å
α=90.00° β=94.5460(10)° γ=90.00°
L-alanyl-L-phenylalanine--2-propanol solvate (1/2)
C18H32N2O5
Acta Crystallographica Section C (1999) 55, 12 2171-2177
a=5.4835(4)Å b=12.3418(8)Å c=29.4245(19)Å
α=90.00° β=90.00° γ=90.00°
L-valyl-L-phenylalanine--2-propanol solvate (1/1)
C17H28N2O4
Acta Crystallographica Section C (1999) 55, 12 2171-2177
a=9.8958(2)Å b=22.3517(6)Å c=16.4571(3)Å
α=90.00° β=90.0230(10)° γ=90.00°
L-Alanyl-L-leucine hemihydrate
C9H18N2O3,0.5H2O1
Acta Crystallographica Section C (1999) 55, 12 IUC9900149
a=33.1828(16)Å b=6.3349(7)Å c=5.5592(8)Å
α=90.00° β=92.406(7)° γ=90.00°
L-leucyl-L-phenylalanine--2-propanol solvate (1/1)
C18H30N2O4
Acta Crystallographica Section C (1999) 55, 12 2171-2177
a=10.0858(2)Å b=16.3754(2)Å c=11.7987(2)Å
α=90.00° β=91.6980(10)° γ=90.00°
DL-aminophenyl acetic acid
C8H9NO2
Acta Crystallographica Section C (1999) 55, 6 IUC9900061
a=15.7794(4)Å b=4.8525(2)Å c=9.8771(3)Å
α=90.00° β=97.9520(10)° γ=90.00°
L-Isoleucine:D-Norleucine
C12H26N2O4
Acta Crystallographica Section B (1999) 55, 3 424-431
a=10.012(2)Å b=4.7227(9)Å c=30.335(6)Å
α=90.00° β=98.38(3)° γ=90.00°
L-Isoleucine:D-Methionine
C11H24N2O4S
Acta Crystallographica Section B (1999) 55, 3 424-431
a=31.7681(3)Å b=4.71700(10)Å c=10.00430(10)Å
α=90.00° β=105.9140(10)° γ=90.00°
L-Isoleucine:D-Valine
C6H13N1O2,C5H11N1O2
Acta Crystallographica Section B (1999) 55, 3 424-431
a=5.25280(10)Å b=23.9809(6)Å c=5.42000(10)Å
α=90.00° β=110.4200(10)° γ=90.00°
L-Isoleucine:D-Leucine
C6H13N1O2,C6H13N1O2
Acta Crystallographica Section B (1999) 55, 3 424-431
a=5.1933(3)Å b=5.4064(3)Å c=13.6968(7)Å
α=91.516(2)° β=98.603(2)° γ=110.376(2)°
L-leucyl-L-valine methanol (1:1)
C12H26N2O4
Acta Crystallographica, Section B: Structural Science (1999) 55, 1 104-113
a=5.28900(10)Å b=12.68770(10)Å c=11.48720(10)Å
α=90.00° β=95.8136(5)° γ=90.00°
L-leucyl-L-valine 2-propanol (1:1)
C14H30N2O4
Acta Crystallographica, Section B: Structural Science (1999) 55, 1 104-113
a=5.17090(10)Å b=14.6136(2)Å c=22.4230(4)Å
α=90.00° β=90.00° γ=90.00°
L-leucyl-L-valine ethanol (1:1)
C13H28N2O4
Acta Crystallographica, Section B: Structural Science (1999) 55, 1 104-113
a=11.01120(10)Å b=23.51860(10)Å c=12.26360(10)Å
α=90.00° β=90.0121(8)° γ=90.00°
C8H13N4O3,C13H15N2O5,H2O1
C8H13N4O3,C13H15N2O5,H2O1
Acta Crystallographica Section C (1993) 49, 9 1673-1676
a=5.052(4)Å b=11.950(9)Å c=18.985(7)Å
α=90.° β=94.88(5)° γ=90.°
L-leucyl-L-alanine tetrahydrate
C9H26N2O7
Acta Crystallographica Section C (1997) 53, 6 736-739
a=6.1863(2)Å b=12.5481(4)Å c=19.8831(6)Å
α=90.00° β=90.00° γ=90.00°
(+-)-tert-Butyl 3-Hydroxy-4-methyl-2-[(toluolsulfonyl)amino]butanoate
C22H29NO5S,CH2Cl2
Acta Crystallographica Section C (1997) 53, 9 1302-1305
a=14.4318(14)Å b=10.2646(10)Å c=17.997(2)Å
α=90.00° β=103.6890(10)° γ=90.00°
L-isoleucine
C6H13NO2
Acta Crystallographica Section C (1996) 52, 6 1464-1466
a=9.681(5)Å b=5.301(3)Å c=13.956(6)Å
α=90.00° β=96.16(4)° γ=90.00°
L-Norvaline:D-Norleucine
C5H11NO2,C6H13NO2
Acta Crystallographica Section C (1999) 55, 7 1105-1112
a=9.9166(2)Å b=4.72470(10)Å c=15.3292(3)Å
α=90.00° β=102.3490(10)° γ=90.00°
L-Methionine:D-Norleucine
C5H11NO2S,C6H13NO2
Acta Crystallographica Section C (1999) 55, 7 1105-1112
a=9.8756(2)Å b=4.70290(10)Å c=16.4192(3)Å
α=90.00° β=107.3283(7)° γ=90.00°
L-Valine:D-Norleucine
C5H11NO2,C6H13NO2
Acta Crystallographica Section C (1999) 55, 7 1105-1112
a=29.5751(4)Å b=4.73860(10)Å c=9.94020(10)Å
α=90.00° β=102.7111(8)° γ=90.00°
L-Leucine:D-Norleucine
C6H13NO2,C6H13NO2
Acta Crystallographica Section C (1999) 55, 7 1105-1112
a=5.17780(10)Å b=27.8078(5)Å c=5.39950(10)Å
α=90.00° β=112.3030(10)° γ=90.00°
L-leucine:D-2-aminobutanoic acid
C6H13NO2.C4H9NO2
Acta Crystallographica Section C (1999) 55, 9 1547-1555
a=5.16730(10)Å b=23.9998(4)Å c=5.40290(10)Å
α=90.00° β=112.0260(10)° γ=90.00°
L-Leucine:D-2-aminopentanoic acid
C6H13NO2.C5H11NO2
Acta Crystallographica Section C (1999) 55, 9 1547-1555
a=5.16390(10)Å b=5.40760(10)Å c=13.1241(2)Å
α=91.7790(10)° β=98.1380(10)° γ=111.8230(10)°
L-Leucine:D-methionine
C6H13NO2.C5H11NO2S
Acta Crystallographica Section C (1999) 55, 9 1547-1555
a=5.14510(10)Å b=28.0517(5)Å c=5.40680(10)Å
α=90.00° β=111.4230(10)° γ=90.00°
L-leucine:D-valine
C6H13NO2.C5H11NO2
Acta Crystallographica Section C (1999) 55, 9 1547-1555
a=5.20020(10)Å b=25.1334(4)Å c=5.41570(10)Å
α=90.00° β=110.7960(10)° γ=90.00°
L-valine:D-2-aminopentanoic acid
C5H11NO2.C5H11NO2
Acta Crystallographica Section C (1999) 55, 9 1547-1555
a=27.2288(2)Å b=4.73970(10)Å c=9.95350(10)Å
α=90.00° β=96.0910(10)° γ=90.00°
L-valine:D-2-aminobutanoic acid
C5H11NO2.C4H9NO2
Acta Crystallographica Section C (1999) 55, 9 1547-1555
a=9.95620(10)Å b=4.74170(10)Å c=12.78330(10)Å
α=90.00° β=106.8430(10)° γ=90.00°
L-valine:D-methionine
C5H11NO2.C5H11NO2S
Acta Crystallographica Section C (1999) 55, 9 1547-1555
a=28.9379(2)Å b=4.70320(10)Å c=10.00110(10)Å
α=90.00° β=90.00° γ=90.00°
Cyclo(L-tyrosyl-L-tryptophanyl) dimethylformamide solvate
C20H19N3O3,C3H7NO
Acta Crystallographica Section E (2008) 64, 2 o436-o436
a=6.1923(2)Å b=15.3873(5)Å c=11.3780(3)Å
α=90.00° β=96.6610(10)° γ=90.00°
Rochelle salt
K,Na,C4H4O62,4(H2O)
Acta Crystallographica Section E (2008) 64, 4 m507-m508
a=11.7859(6)Å b=14.1972(7)Å c=6.1875(3)Å
α=90.00° β=90.00° γ=90.00°
Phloroglucinol
C6H6O3
Acta Crystallographica Section E (2008) 64, 10 o2023
a=4.7778(2)Å b=9.3581(4)Å c=12.4433(6)Å
α=90.00° β=90.00° γ=90.00°
(2SR,3RS)-Benzyl[4-chloro-1-(4-chlorophenyl)-1-methoxycarbonyl- 2-butyl]ammonium chloride
C19H22Cl2NO2,Cl
Acta Crystallographica Section E (2008) 64, 10 o2038
a=9.263(2)Å b=10.432(3)Å c=11.490(3)Å
α=115.954(3)° β=93.925(3)° γ=103.015(3)°
L-prolyl-L-serine
C8H14N2O4,H2O
Acta Crystallographica Section C (2013) 69, 5 556-559
a=5.3101(12)Å b=29.081(7)Å c=6.6757(15)Å
α=90.00° β=90.829(3)° γ=90.00°
(2<i>S</i>,3<i>S</i>)-2,6-Dimethylheptane-1,3-diol
C9H20O2
Acta Crystallographica Section C (2013) 69, 6 647-650
a=5.964(2)Å b=9.777(4)Å c=17.469(6)Å
α=90.00° β=90.00° γ=90.00°
(<i>R</i>)-4-Benzyl-3-[(2<i>R</i>,3<i>S</i>)-3-hydroxy-2,6-dimethylheptanoyl]-1,3-oxazolidin-2-one
C19H27NO4
Acta Crystallographica Section C (2013) 69, 6 647-650
a=11.459(3)Å b=5.7077(13)Å c=15.247(3)Å
α=90.00° β=103.827(3)° γ=90.00°
L-Phenylalanyl-L-alanine dihydrate
C12H16N2O3,2H2O1
Acta Crystallographica Section C (2001) 57, 5 575-576
a=7.6541(2)Å b=11.0918(3)Å c=17.5990(5)Å
α=90.00° β=90.00° γ=90.00°
L-Methionyl-L-alanine
C8H16N2O3S
Acta Crystallographica Section C (2003) 59, 10 o589-o592
a=37.6488(15)Å b=37.6488(15)Å c=9.6613(8)Å
α=90° β=90° γ=120°
L-Isoleucyl-L-phenylalanine
C15H26N2O5
Acta Crystallographica Section C (2004) 60, 5 o371-o373
a=5.6350(14)Å b=8.2897(18)Å c=17.382(4)Å
α=90.00° β=99.256(9)° γ=90.00°
L-Phenylalanine--D-2-aminobutyric acid (1/1)
C9H11NO2,C4H9NO2
Acta Crystallographica Section C (2009) 65, 6 o267-o272
a=4.7869(7)Å b=9.9558(15)Å c=28.423(4)Å
α=90.00° β=90.00° γ=90.00°
L-Phenylalanine--D-norvaline (1/1)
C9H11NO2,C5H11NO2
Acta Crystallographica Section C (2009) 65, 6 o267-o272
a=4.7624(8)Å b=9.9569(17)Å c=30.935(6)Å
α=90.00° β=90.00° γ=90.00°
L-Phenylalanine--D-methionine (1/1)
C9H11NO2,C5H11NO2S
Acta Crystallographica Section C (2009) 65, 6 o267-o272
a=10.110(2)Å b=4.7064(9)Å c=16.686(3)Å
α=90.00° β=106.663(2)° γ=90.00°
L-Phenylalanine--D-isoleucine (1/1)
C9H11NO2,C6H13NO2
Acta Crystallographica Section C (2009) 65, 6 o267-o272
a=5.2317(12)Å b=5.4232(12)Å c=14.459(3)Å
α=85.936(3)° β=85.343(3)° γ=70.424(2)°
L-Phenylalanine--D-alloisoleucine (1/1)
C9H11NO2,C6H13NO2
Acta Crystallographica Section C (2009) 65, 6 o267-o272
a=5.2436(5)Å b=28.949(3)Å c=5.4069(5)Å
α=90.00° β=109.7470(10)° γ=90.00°
Trimesic acid--pyrazine <i>N</i>,<i>N</i>'-dioxide (2/1)
2(C9H6O6),C4H4N2O2
Acta Crystallographica Section C (2014) 70, 1 43-45
a=7.9521(2)Å b=8.0939(2)Å c=8.6271(2)Å
α=78.6210(10)° β=80.7000(10)° γ=79.7690(10)°
L-Seryl-L-phenylalanine
C12H16N2O4
Acta Crystallographica Section C (2004) 60, 10 o771-o772
a=5.3382(13)Å b=6.3827(16)Å c=36.741(9)Å
α=90.00° β=90.00° γ=90.00°
2-(L-alanylamino)-L-butyric acid
C7H14N2O3,0.33H2O
Acta Crystallographica Section C (2002) 58, 8 o533-o536
a=15.4292(5)Å b=5.4602(2)Å c=18.1320(6)Å
α=90° β=113.5050(10)° γ=90°
N-(L-2-aminobutyryl)-L-alanine
C7H14N2O3
Acta Crystallographica Section C (2002) 58, 8 o533-o536
a=17.9290(12)Å b=17.9290(12)Å c=5.2196(5)Å
α=90° β=90° γ=90°
L-phenylalanyl-L-tryptophan 0.75-hydrate
C20H21N3O3,0.75H2O
Acta Crystallographica Section C (2006) 62, 6 o328-o330
a=5.6207(6)Å b=35.556(4)Å c=35.835(4)Å
α=90.00° β=90.00° γ=90.00°
L-Seryl-L-valine
C8H16N2O4
Acta Crystallographica Section C (2004) 60, 8 o564-o565
a=5.383(4)Å b=6.315(4)Å c=15.588(10)Å
α=90.00° β=98.623(6)° γ=90.00°
1,1,3,3-tetramethylguanidine <i>p</i>-toluenesulfinate
C5H14N3,C7H7O2S
Acta Crystallographica Section C (2013) 69, 7 778-780
a=11.0959(8)Å b=7.4038(5)Å c=17.1944(13)Å
α=90.00° β=92.1150(10)° γ=90.00°
1,1,3,3-tetramethylguanidine <i>p</i>-toluenesulfonate
C5H14N3,C7H7O2.82S
Acta Crystallographica Section C (2013) 69, 7 778-780
a=11.185(3)Å b=7.648(2)Å c=17.415(5)Å
α=90.00° β=93.169(4)° γ=90.00°
Abu-Ser, N-(L-2-aminobutyryl)-L-serine
C7H14N2O4
Acta Crystallographica Section C (2013) 69, 8 888-891
a=18.335(7)Å b=18.335(7)Å c=5.141(2)Å
α=90.00° β=90.00° γ=90.00°
Taurine
C2H7NO3S
Acta Crystallographica Section C (2000) 56, 1 e23-e24
a=5.27290(10)Å b=11.6565(3)Å c=7.8383(2)Å
α=90.00° β=94.0110(10)° γ=90.00°
L-Seryl-L-Alanine
C6H12N2O4
Acta Crystallographica Section C (2000) 56, 4 500-502
a=4.84880(10)Å b=14.8294(4)Å c=6.0228(2)Å
α=90.00° β=110.5340(10)° γ=90.00°
<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-α-aminoisobutyryl-α-aminoisobutyric acid methyl ester
C14H26N2O5
Acta Crystallographica Section C (2011) 67, 8 o283-o287
a=6.116(3)Å b=15.662(7)Å c=17.967(8)Å
α=90.00° β=97.878(6)° γ=90.00°
Boc-Aib-Aib-OMe
C14H26N2O5
Acta Crystallographica Section C (2011) 67, 8 o283-o287
a=6.0679(15)Å b=33.743(9)Å c=8.583(2)Å
α=90.00° β=92.266(3)° γ=90.00°
Boc-L-Val-L-Val-OMe
C16H30N2O5
Acta Crystallographica Section C (2011) 67, 8 o278-o282
a=11.6937(12)Å b=18.6458(19)Å c=27.047(3)Å
α=90.00° β=90.00° γ=90.00°
Glycyl-L-valine
C7H14N2O3
Acta Crystallographica Section C (2007) 63, 1 o58-o60
a=5.5238(7)Å b=26.581(3)Å c=44.093(5)Å
α=90.00° β=90.00° γ=90.00°
L-Isoleucyl-L-asparagine
C10H19N3O4,1.094H2O
Acta Crystallographica Section C (2010) 66, 7 o349-o352
a=4.7855(4)Å b=18.2887(15)Å c=31.247(3)Å
α=90.00° β=90.00° γ=90.00°
L-Seryl-L-asparagine monohydrate
C7H13N3O5,H2O
Acta Crystallographica Section C (2008) 64, 3 o171-o176
a=4.75470(10)Å b=7.5121(2)Å c=8.5626(2)Å
α=115.6910(10)° β=90.2660(10)° γ=104.9570(10)°
L-Seryl-L-tyrosine monohydrate
C12H16N2O5,H2O
Acta Crystallographica Section C (2008) 64, 3 o171-o176
a=15.3480(9)Å b=17.8805(11)Å c=4.7728(3)Å
α=90.00° β=90.00° γ=90.00°
L-tyrosyl-L-tryptophane monohydrate
C20H21N3O4,H2O
Acta Crystallographica Section C (2008) 64, 3 o171-o176
a=5.7309(3)Å b=8.1960(4)Å c=19.0952(9)Å
α=90.00° β=91.6940(10)° γ=90.00°
L-Phenylalanyl-L-valine
C14H20N2O3
Acta Crystallographica Section C (2000) 56, 12 1496-1498
a=5.0955(3)Å b=13.2155(7)Å c=20.1670(11)Å
α=90.00° β=90.00° γ=90.00°
L-Methionyl-L-alanine 2-propanol solvate
C8H16N2O3S,2C3H8O1
Acta Crystallographica Section C (2000) 56, 2 e64-e65
a=9.9277(2)Å b=16.4556(3)Å c=12.4895(2)Å
α=90.00° β=97.5940(10)° γ=90.00°
L-Alanyl-L-methionine hemihydrate
C8H16N2O3S,0.5H2O
Acta Crystallographica Section C (2003) 59, 12 o730-o732
a=5.0809(2)Å b=17.9228(9)Å c=24.5005(11)Å
α=90.00° β=90.00° γ=90.00°
L-phenylalanyl-L-serine
C12H16N2O4
Acta Crystallographica Section C (2006) 62, 1 o22-o25
a=7.6434(7)Å b=5.7609(5)Å c=13.4396(12)Å
α=90.00° β=93.754(4)° γ=90.00°
L-isoleucyl-L-serin 0.33-hydrate
C9H18N2O4,0.33H2O
Acta Crystallographica Section C (2006) 62, 1 o22-o25
a=16.9692(11)Å b=5.2167(3)Å c=12.4065(8)Å
α=90.00° β=90.9420(10)° γ=90.00°
L-Methionyl-L-Serine 0.34-hydrate
C8H16N2O4S,0.34H2O
Acta Crystallographica Section C (2006) 62, 1 o22-o25
a=16.791(4)Å b=5.0711(11)Å c=26.851(6)Å
α=90.00° β=100.926(4)° γ=90.00°
L-Phenyl-L-isoleucine
C15H22N2O3,0.88H2O
Acta Crystallographica Section C (2004) 60, 11 o810-o812
a=5.5634(3)Å b=17.0558(9)Å c=16.6859(9)Å
α=90.00° β=96.7440(10)° γ=90.00°
L-Valyl-L-serine trihydrate
C8H16N2O4,3H2O
Acta Crystallographica Section C (2005) 61, 4 o198-o200
a=4.7695(2)Å b=16.1323(5)Å c=8.6789(3)Å
α=90.00° β=103.6360(10)° γ=90.00°